Samples | half-wave potential (mV) (vs. SHE) | Electrode | references |
---|---|---|---|
HLMWb5 | -19.5 | Au* | present study |
LMWb5 | -21 | Au* | [32] |
full-length human cyt. b5 | -20.5 | Au* | present study |
L51I | -30.5 | Au* | present study |
A59V | -29 | Au* | present study |
A59S | -31.5 | Au* | present study |
G67A | -40.5 | Au* | present study |
G67S | -32 | Au* | present study |
human erythrocyte cyt. b5 | -9 | Au** | [42] |
rat OM cyt. b5 (soluble domain) | +8 | Au* | [25] |
rat OM cyt. b5 (soluble domain) | -40 | Au*+Mg2+ | [25] |
rat OM cyt. b5 (soluble domain) | -78 | Au*+Cr3+ | [25] |
rat OM cyt. b5 (soluble domain) | -27 | Carbon | [28] |
DiMe OM cyt. b5 (soluble domain) | +20 | Carbon | [28] |
V61L/V45L | -14 | Carbon | [28] |
rat OM cyt. b5 (soluble domain) | -26 | ITO | [29] |
DiMe OM cyt. b5 (soluble domain) | +4 | ITO | [29] |
V61I/V45I | -24 | ITO | [29] |
rat liver cyt. b5 (soluble domain) | +16.2 | Au*2 | [38] |
A67V (soluble domain) | -2.8 | Au*2 | [38] |
rat liver cyt. b5 (soluble domain) | -7 | Au*3 | [47] |
bovine liver cyt. b5 (tryptic fragment) | Â | Â | Â |
   + 20 mM Mg2+ | -6 | Au*4 | [44] |
bovine liver cyt. b5 (tryptic fragment) | Â | Â | Â |
   + 20 mM Cr(NH3)63+ | -14 | Au*4 | [44] |
bovine liver cyt. b5 (tryptic fragment) | -10 | Au*3 | [18] |
V61E (bovine liver, tryptic) | -25 | Au*3 | [18] |
V61Y (bovine liver, tryptic) | -33 | Au*3 | [18] |
V61H (bovine liver, tryptic) | +11 | Au*3 | [18] |
V61K (bovine liver, tryptic) | +17 | Au*3 | [18] |
V45Y | -35 | Au*3 | [48] |
V45H | +8 | Au*3 | [48] |
V45E | -26 | Au*3 | [48] |